PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 128 filers reported holding PUMA BIOTECHNOLOGY INC in Q3 2020. The put-call ratio across all filers is 1.91 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $1,662,000 | -35.2% | 180,938 | -31.5% | 0.00% | 0.0% |
| Q1 2021 | $2,564,000 | -2.1% | 264,092 | +3.4% | 0.00% | 0.0% |
| Q4 2020 | $2,619,000 | -0.0% | 255,309 | -1.7% | 0.00% | 0.0% |
| Q3 2020 | $2,620,000 | +18.8% | 259,750 | +22.7% | 0.00% | 0.0% |
| Q2 2020 | $2,206,000 | +59.0% | 211,695 | +28.7% | 0.00% | 0.0% |
| Q1 2020 | $1,387,000 | +10.8% | 164,521 | +15.0% | 0.00% | 0.0% |
| Q4 2019 | $1,252,000 | -16.0% | 143,118 | +3.4% | 0.00% | 0.0% |
| Q3 2019 | $1,491,000 | -5.8% | 138,444 | +11.1% | 0.00% | 0.0% |
| Q2 2019 | $1,583,000 | -84.7% | 124,605 | -53.4% | 0.00% | -80.0% |
| Q1 2019 | $10,371,000 | +48.5% | 267,293 | -22.1% | 0.01% | +66.7% |
| Q4 2018 | $6,982,000 | -53.2% | 343,064 | +5.4% | 0.00% | -40.0% |
| Q3 2018 | $14,924,000 | -24.7% | 325,565 | -2.9% | 0.01% | -44.4% |
| Q2 2018 | $19,822,000 | -29.0% | 335,120 | -18.3% | 0.01% | -30.8% |
| Q1 2018 | $27,904,000 | -14.0% | 410,034 | +25.0% | 0.01% | -13.3% |
| Q4 2017 | $32,428,000 | +63.6% | 328,063 | +98.2% | 0.02% | +66.7% |
| Q3 2017 | $19,824,000 | +38.3% | 165,547 | +0.9% | 0.01% | +28.6% |
| Q2 2017 | $14,339,000 | +0.4% | 164,104 | -57.3% | 0.01% | 0.0% |
| Q1 2017 | $14,286,000 | +19.6% | 384,035 | -1.3% | 0.01% | 0.0% |
| Q4 2016 | $11,948,000 | -16.8% | 389,183 | +81.7% | 0.01% | -12.5% |
| Q3 2016 | $14,362,000 | +2063.0% | 214,192 | +846.8% | 0.01% | – |
| Q1 2016 | $664,000 | -59.2% | 22,623 | +9.0% | 0.00% | -100.0% |
| Q4 2015 | $1,626,000 | -0.9% | 20,746 | -4.6% | 0.00% | 0.0% |
| Q3 2015 | $1,640,000 | -50.4% | 21,746 | -23.3% | 0.00% | -50.0% |
| Q2 2015 | $3,309,000 | -72.0% | 28,349 | -43.4% | 0.00% | -71.4% |
| Q1 2015 | $11,822,000 | +9.7% | 50,077 | -12.1% | 0.01% | +16.7% |
| Q4 2014 | $10,781,000 | +2.0% | 56,962 | +28.6% | 0.01% | 0.0% |
| Q3 2014 | $10,565,000 | +301.7% | 44,285 | +11.1% | 0.01% | +200.0% |
| Q2 2014 | $2,630,000 | +907.7% | 39,852 | +1485.2% | 0.00% | – |
| Q1 2014 | $261,000 | -47.7% | 2,514 | -47.9% | 0.00% | – |
| Q4 2013 | $499,000 | -95.7% | 4,824 | -97.8% | 0.00% | -100.0% |
| Q3 2013 | $11,711,000 | +110.1% | 218,250 | +73.7% | 0.01% | +100.0% |
| Q2 2013 | $5,575,000 | – | 125,615 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,300,000 | $12,636,000 | 2.61% |
| AIGH Capital Management LLC | 964,590 | $9,376,000 | 1.97% |
| Worth Venture Partners, LLC | 226,758 | $2,204,000 | 1.07% |
| Camber Capital Management LP | 2,555,000 | $24,835,000 | 0.85% |
| Palo Alto Investors LP | 1,392,997 | $13,540,000 | 0.77% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,769,795 | $36,642,000 | 0.77% |
| GLOBEFLEX CAPITAL L P | 428,680 | $4,167,000 | 0.76% |
| Zebra Capital Management LLC | 34,243 | $333,000 | 0.37% |
| Sofinnova Investments, Inc. | 344,917 | $3,353,000 | 0.20% |
| RICE HALL JAMES & ASSOCIATES, LLC | 605,792 | $5,888,000 | 0.19% |